Abstract: The present disclosure relates to a pharmaceutical composition of a combination of tramadol-etoricoxib hydrochloride for the treatment of pain. The production method of the pharmaceutical composition is based on two active ingredients including granules and/or multi-particulates containing tramadol hydrochloride and granules and/or multi-particulates containing etoricoxib. The pharmaceutical composition can be contained in a mixture of powders, included in a two-layer tablet with or without a coating, or in a capsule as granulates and/or tablets with or without a coating.
Type:
Application
Filed:
May 11, 2017
Publication date:
February 28, 2019
Applicant:
Laboratorios Liomont, S.A. DE C.V.
Inventors:
Reyna Astrid SALTO RIVERA, Oliver Daniel WALLS FLORES, Ramón RODRÍGUEZ HERNÁNDEZ
Abstract: A new presentation of an antiviral pharmaceutical composition in solution form comprising as an active agent, aciclovir in an amount of about 5% by weight; a solvent in an amount of from about 10 to 20% by weight; a solubilizing agent in an amount of from about 1.5 to 5.0% by weight; a humectant agent in an amount of from about 2 to 10% by weight; an anti-itching agent in an amount of from about 0.05 to 1.0% by weight; an antioxidant agent in an amount of from about 0.1 to 0.5% by weight and demineralized water in an amount of from about 20 to 80% by weight.
Abstract: A new presentation of an antiviral pharmaceutical composition in solution form comprising as an active agent, aciclovir in an amount of about 5% by weight; a solvent in an amount of from about 10 to 20% by weight; a solubilizing agent in an amount of from about 1.5 to 5.0% by weight; a humectant agent in an amount of from about 2 to 10% by weight; an anti-itching agent in an amount of from about 0.05 to 1.0% by weight; an antioxidant agent in an amount of from about 0.1 to 0.5% by weight and demineralized water in an amount of from about 20 to 80% by weight.